Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 13.59 B13.78 B15.22 B17 B15.39 B 61.39 B Research & development ————— — Operating income 9.12 B5.15 B4.32 B380 M8.99 B 18.84 B Non-Operating Income, Total 1.03 B1.11 B1.13 B647 M1.13 B 4.02 B Interest expense, net of interest capitalized 998 M1.03 B1 B974 M955 M 3.96 B Non-Operating Income, excl. Interest Expenses 35 M81 M129 M-327 M176 M 59 M Unusual income/expense ————— — Pretax income 8.11 B4.08 B3.23 B-720 M7.96 B 14.55 B Equity in earnings ————— — Taxes 1.63 B510 M686 M-938 M1.48 B 1.74 B Non-controlling/minority interest 182 M166 M195 M208 M201 M 770 M After tax other income/expense -97 M-30 M63 M-1.61 B304 M -1.27 B Net income before discontinued operations 6.29 B3.41 B2.35 B10 M6.28 B 12.04 B Discontinued operations ————— — Net income 6.29 B3.41 B2.35 B10 M6.28 B 12.04 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 6.29 B3.41 B2.35 B10 M6.28 B 12.04 B Basic earnings per share (Basic EPS) 6.93.762.590.036.92 13.3 Diluted earnings per share (Diluted EPS) 6.853.742.590.056.9 13.28 Average basic shares outstanding 912 M907 M906 M908 M908 M — Diluted shares outstanding 918 M910 M908 M911 M910 M — EBITDA ———2.08 B— — EBIT 9.12 B5.15 B4.32 B380 M8.99 B 18.84 B Cost of revenue 85.8 B91.6 B92.52 B94.72 B86.31 B 365.16 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) ———1.7 B— —